The boundary between science fiction and medical reality blurs as companies like Elon Musk's Neuralink make strides in ...

Imagine moving a computer mouse with only your thoughts. You think it, and it's done. It may be science fiction, but it's ...

The new director at the FDA overseeing medical devices will confront criticisms about hasty approvals as she ushers in ...

Neuralink has claimed in a tweet that it has finally received approval from the FDA to start a first-in-human clinical trial of its brain implant chip – but hasn’t indicated when it may start.

Neuralink’s journey began with ambitious goals to revolutionise treatment for neurological conditions through advanced BCI technology. Following FDA approval for human trials in May 2023, the company ...

FDA approves Autolus Therapeutics' Aucatzyl for adults with relapsed or refractory B-cell precursor acute lymphoblastic ...

Journey Medical has claimed FDA approval for its Emrosi therapy for rosacea, which it thinks could become a "standard of care" drug for the common skin disorder. The new capsule formulation of the ...

The RNS System Post-Approval Study (PAS) is the largest prospective post-approval study in neuromodulation for patients with drug-resistant focal ...

Journey Medical (DERM) announced that the FDA has approved Emrosi, formerly referred to as DFD-29, for the treatment of inflammatory lesions of ...

U.S. District Judge Amit P. Mehta ruled in favor of Latham, upholding FDA approval of the narcolepsy drug Lumryz. A federal court ruled in favor of Latham & Watkins and against Sidley Austin in a ...